[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370449-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370449-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","deficiency-of-mtap-is-frequent-and-mostly-homogeneous-in-pancreatic-ductal-adenocarcinomas","Deficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal Adenocarcinomas","","S-methyl-5′-thioadenosine phosphorylase (MTAP) expression loss, commonly caused by homozygous 9p21 deletion, represents a druggable vulnerability in pancreatic cancer cells. The study analyzed 769 primary pancreatic ductal adenocarcinomas using tissue microarrays with MTAP immunohistochemistry and 9p21 fluorescence in situ hybridization. Intratumoral heterogeneity was evaluated on a heterogeneity TMA and by whole-section analysis. MTAP loss occurred in 37.9% of interpretable tumors, was driven by homozygous deletion, showed minimal heterogeneity, and IHC closely matched FISH deletion status.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/deficiency-of-mtap-is-frequent-and-mostly-homogeneous-in-pancreatic-ductal-adenocarcinomas/370449/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/deficiency-of-mtap-is-frequent-and-mostly-homogeneous-in-pancreatic-ductal-adenocarcinomas/370449.png","ImageObject",300,407,{"name":42,"@type":43},"Mia  ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What causes MTAP deficiency in pancreatic ductal adenocarcinomas?","Question",{"text":63,"@type":64},"MTAP deficiency is often caused by homozygous 9p21 deletion, which leads to complete MTAP expression loss.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How often was MTAP expression loss detected, and is it related to clinicopathologic factors?",{"text":68,"@type":64},"MTAP expression loss was found in 37.9% of interpretable primary tumors and was unrelated to pT, pN, grade, and tumor size.",{"name":70,"@type":61,"acceptedAnswer":71},"How heterogeneous is MTAP loss within tumors?",{"text":72,"@type":64},"MTAP loss was mostly homogeneous: it was homogeneous in 37.6% and heterogeneous in 1.1% of MTAP-deficient tumors on the heterogeneity TMA; whole sections showed heterogeneous loss in 1 of 19 tumors.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370449,1790466294,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article  \nDeficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal Adenocarcinomas  \nNatalia Gorbokon 1, Katharina Teljuk 1, Viktor Reiswich 1, Maximilian Lennartz 1, Sarah Minner 1, Ronald Simon 1, *, Guido Sauter 1, Waldemar Wilczak 1, Till Sebastian Clauditz 1, Nina Schraps 2,  \nThilo Hackert 2, Faik G. Uzunoglu 2, Martina Kluth 1, Lukas Bubendorf 3, Matthias Matter 3, Florian Viehweger 1, Morton Freytag 1, Frank Jacobsen 4, Katharina Möller 1 and Stefan Steurer 1  \nAcademic Editor: Akiteru Goto  \nReceived: 3 February 2025  \nRevised: 19 March 2025  \nAccepted: 20 March 2025  \nPublished: 1 April 2025  \nCitation: Gorbokon, N.; Teljuk, K.; Reiswich, V.; Lennartz, M.; Minner, S.; Simon, R.; Sauter, G.; Wilczak, W.; Clauditz, T.S.; Schraps, N.; et al. Deficiency of MTAPIs Frequent and Mostly Homogeneous in Pancreatic DuctalAdenocarcinomas. Cancers 2025, 17, 1205. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/cancers17071205](10.3390/cancers17071205)  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Institute of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; [n.gorbokon@uke.de](n.gorbokon@uke.de) (N.G.); [k.teljuk@freenet.de](k.teljuk@freenet.de) (K.T.); [v.reiswich@uke.de](v.reiswich@uke.de) (V.R.); [m.lennartz@uke.de](m.lennartz@uke.de) (M.L.); [s.minner@uke.de](s.minner@uke.de) (S.M.); [g.sauter@uke.de](g.sauter@uke.de) (G.S.); [w.wilczak@uke.de](w.wilczak@uke.de) (W.W.); [t.clauditz@uke.de](t.clauditz@uke.de) (T.S.C.); [m.kluth@uke.de](m.kluth@uke.de) (M.K.); [f.viehweger@uke.de](f.viehweger@uke.de) (F.V.); [ka.moeller@uke.de](ka.moeller@uke.de) (K.M.); [s.steurer@uke.de](s.steurer@uke.de) (S.S.)  \n2 General, Visceral and Thoracic Surgery Department and Clinic, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; [n.schraps@uke.de](n.schraps@uke.de) (N.S.); [t.hackert@uke.de](t.hackert@uke.de) (T.H.); [f.uzunoglu@uke.de](f.uzunoglu@uke.de) (F.G.U.)  \n3 Institute of Pathology, University Hospital Basel, 4031 Basel, Switzerland; [lukas.bubendorf@usb.ch](lukas.bubendorf@usb.ch) (L.B.); [matthias.matter@usb.ch](matthias.matter@usb.ch) (M.M.)  \n4 Pathologie-Hamburg, Labor Lademannbogen MVZ GmbH, 22419 Hamburg, Germany; f.jacobsen@uke.de  \n* Correspondence: [r.simon@uke.de](r.simon@uke.de); Tel.: +49-40-7410-57214; Fax: +49-40-7410-55997  \nSimple Summary: Ductal adenocarcinoma of the pancreas is a cancer with exceedingly dismal prognosis as less than 5% of all patients survive more than 5 years. Therefore, targeted molecular therapies are urgently needed. MTAP deficiency is currently one of the most promising molecular targets for tumor therapies. MTAP deficiency—often caused by homozygous 9p21 deletion—is easily detectable by immunohistochemistry because it is characterized by a complete MTAP expression loss. It makes tumor cells more susceptible to PRMT5-and MAT2A-inhibiting drugs as well as to pemetrexed (antifolate therapy) . However, the success of targeted therapies critically depends on the extent of heterogeneity of the targeted tumor cell trait in clinical tumors. In this study, intratumoral heterogeneity of MTAP deficiency was thus assessed in more than 200 ductal adenocarcinomas of the pancreas in a tissue microarray format and whole-section analysis was carried out by immunohistochemistry and fluorescence in situ hybridization. MTAP deficiency was found in almost 40% of all cancers, was always caused by homozygous deletion, and was rarely heterogenous in TMA and large-section analyses (less than 10%) . Pancreatic adenocarcinomas may thus represent an ideal cancer type for studying new drugs targeting MTAP-deficient cancer cells in clinical trials. ","cbCaig13vWLK3gNt","https://ap.wps.com/l/cbCaig13vWLK3gNt","pdf",3301088,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions","[{\"question\":\"What causes MTAP deficiency in pancreatic ductal adenocarcinomas?\",\"answer\":\"MTAP deficiency is often caused by homozygous 9p21 deletion, which leads to complete MTAP expression loss.\"},{\"question\":\"How often was MTAP expression loss detected, and is it related to clinicopathologic factors?\",\"answer\":\"MTAP expression loss was found in 37.9% of interpretable primary tumors and was unrelated to pT, pN, grade, and tumor size.\"},{\"question\":\"How heterogeneous is MTAP loss within tumors?\",\"answer\":\"MTAP loss was mostly homogeneous: it was homogeneous in 37.6% and heterogeneous in 1.1% of MTAP-deficient tumors on the heterogeneity TMA; whole sections showed heterogeneous loss in 1 of 19 tumors.\"}]","Deficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal Adenocarcinomas | PDF",1790188542,33,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca559fe078e667365c8454b13cbf3439.webp",983,1390,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0e75d4e4cd302a66acb0354a9deb024.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4bb8db2663f9c55111b07920a2b9a44a.webp",981,1387,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b44771fb08ecdebc5f1e59a2300eb78.webp",980,1385]